Company intelligence / Profile preview

Mid-Atlantic Capital Alliance

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Mid-Atlantic Capital Alliance (MACA) is a specialized investment and advisory firm that focuses on the life sciences, healthcare, and biotechnology sectors. The company provides strategic capital, merger and acquisition advisory services, and business development support to emerging and mid-market healthcare companies. MACA leverages its deep industry expertise to identify high-potential therapeutic and diagnostic opportunities, facilitating growth through structured financing and strategic partnerships. While not a drug developer itself, the firm plays a critical role in the ecosystem by bridging the gap between innovative clinical research and the capital necessary for commercialization.

Industry: Investors

Beyond the preview

Go deeper on Mid-Atlantic Capital Alliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mid-Atlantic Capital Alliance.

Explore the full profile